UC Davis
Tzu-yin Cindy Lin is a highly experienced Research Associate Professor at the University of California, Davis, with a strong background in veterinary oncology and pathology. Tzu-yin has played a crucial role in interdisciplinary teams, contributing to the successful acquisition of an Investigational New Drug (IND) and the ongoing multi-center clinical trial. Tzu-yin's experience includes being a Paul Calabresi Clinical Oncology K12 Career Development Award recipient and serving as a Post-doctoral Researcher. As the Founder and Chief Operating Officer of Theranostec Inc, Tzu-yin has led initiatives to commercialize theranostic products, and as the Founder of iCLinpath, Tzu-yin provides real-time global cytology diagnostic services. Previous roles include Senior Principal Investigator at LP Therapeutics, where Tzu-yin led projects to develop nanoparticles for leukemia treatment, as well as a Veterinary Clinical Pathology Resident and Research Fellow at The Ohio State University. Tzu-yin holds a PhD in Veterinary Oncology and Pathology from The Ohio State University and a Doctor of Veterinary Medicine degree from National Taiwan University.
This person is not in the org chart
UC Davis
23 followers
For more than 100 years, UC Davis has engaged in teaching, research and public service that matter to California and transform the world. Located close to the state capital, UC Davis has more than 33,000 students, more than 2,500 faculty and more than 21,000 staff, an annual research budget of nearly $750 million, a comprehensive health system and 13 specialized research centers.